Expertise in
2
conditions

Grzegorz Witkowski

Warsaw, MZ, PL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Warsaw, MZ, PL 

Overview

Grzegorz Witkowski practices practicing medicine in Warsaw, Poland.

Mr. Witkowski is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Huntington Disease, Chorea, Drug Induced Dyskinesia, and Movement Disorders.

He is actively involved in clinical research, co-authoring 24 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

Warsaw, MZ, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Enrollment Status: Recruiting
Publish Date: April 27, 2026
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
A Multicenter, Randomized, Double-blind, Placebo Controlled, Phase 1b/2a Study of WVE-003 Administered Intrathecally in Patients With Huntington's Disease (SELECT-HD)
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Drug
Study Drug: WVE-003
Study Phase: Phase 1/Phase 2
A Phase Ib/II Randomized, Double-Blind Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gene (HTT) Lowering Therapy (AMT 130) in Early Manifest Huntington's Disease
A Phase Ib/II Randomized, Double-Blind Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gene (HTT) Lowering Therapy (AMT 130) in Early Manifest Huntington's Disease
Enrollment Status: Active_not_recruiting
Publish Date: March 10, 2025
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: April 25, 2022
Intervention Type: Drug
Study Drug: WVE-120102
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drug: WVE-120101
Study Phase: Phase 1/Phase 2
View 4 Less Clinical Trials

24 Total Publications

The association between smoking and Huntington's disease symptom onset and progression - results from Enroll-HD: The observational cohort study of people with Huntington's disease.
The association between smoking and Huntington's disease symptom onset and progression - results from Enroll-HD: The observational cohort study of people with Huntington's disease.
Journal: Neurologia i neurochirurgia polska
Published: July 08, 2025

Frequently Asked Questions about Grzegorz Witkowski

Is Grzegorz Witkowski a top-rated expert for Huntington Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Grzegorz Witkowski is classified as an Advanced expert for Huntington Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Grzegorz Witkowski participate in research or clinical trials?

Yes. Grzegorz Witkowski has published 24 articles and abstracts on conditions like Huntington Disease. You can view a list of Grzegorz Witkowski's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Witkowski's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile